Literature DB >> 18790599

Transcutaneous electrical nerve stimulation (TENS) for cancer bone pain.

Robert D Searle1, Michael I Bennett, Mark I Johnson, Sarah Callin, Helen Radford.   

Abstract

In the cancer population, painful bony metastases are common, difficult to treat and significantly reduce quality of life. Common treatments include opioid analgesics, bisphosphonates, and radiotherapy; yet these have significant side effects and are not universally effective. Transcutaneous electrical nerve stimulation (TENS) is inexpensive, relatively free from side effects, and widely available. We present a case study of successful TENS therapy in a patient with cancer bone pain and discuss the rationale for using TENS in this setting.

Entities:  

Mesh：

Year:  2008        PMID： 18790599     DOI： 10.1016/j.jpainsymman.2008.03.017

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN： 0885-3924            Impact factor:   3.612


  3 in total

1.  Pilot in vitro and in vivo study on a mouse model to evaluate the safety of transcutaneous low-frequency electrical nerve stimulation on cervical cancer patients.

Authors:  Shiyan Wang; Xiuli Sun; Wenjin Cheng; Jue Zhang; Jianliu Wang
Journal:  Int Urogynecol J       Date:  2018-04-02       Impact factor: 2.894

2.  Efficacy of Transcutaneous Electrical Nerve Stimulation on Salivary Flow Rates in Normal Healthy Adults According to Gender and Age Groups.

Authors:  C Ramesh; Sharad S Sawant; Deepak R Kolte; Barun Kumar; Kosuru Kranthi; Tejal R Patil; J Suresh Babu; C Swarnalatha; Abhishek Singh Nayyar
Journal:  Asian J Neurosurg       Date:  2021-09-07

3.  Neurophysiological Mechanisms Related to Pain Management in Bone Tumors.

Authors:  Pablo Romero-Morelos; Erika Ruvalcaba-Paredes; David Garciadiego-Cázares; Martín Pérez-Santos; Samuel Reyes-Long; Alfonso Alfaro-Rodriguez; Mauricio Salcedo; Javier Mancilla-Ramírez; Cindy Bandala
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.